Hiroko Kazusaka
Overview
Explore the profile of Hiroko Kazusaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sen M, Ito R, Abe T, Kazusaka H, Matsui M, Saitou M, et al.
Surg Today
. 2025 Jan;
PMID: 39762505
Purpose: Tumor/node/metastasis staging and prognostic index (PI) are used to predict prognosis and guide treatment for anaplastic thyroid carcinoma (ATC). With the advent of treatments, such as BRAF/MEK inhibitors and...
2.
Sugitani I, Nagaoka R, Saitou M, Sen M, Kazusaka H, Matsui M, et al.
World J Surg
. 2024 Nov;
49(1):159-169.
PMID: 39592419
Introduction: Active surveillance (AS) for low-risk papillary thyroid carcinoma (PTC) is acknowledged as a valid management strategy. While older age is identified as a favorable factor for progression, long-term evidence...
3.
Saitou M, Akasu H, Jikuzono T, Sen M, Kazusaka H, Matsui M, et al.
J Nippon Med Sch
. 2024 Nov;
91(5):432-438.
PMID: 39505500
Background: Postoperative bleeding is a potentially life-threatening complication following thyroidectomy, but the risk factors and timing remain insufficiently understood. The bleeding rate for endoscopic surgery, specifically video-assisted neck surgery (VANS),...
4.
Sen M, Ito R, Abe T, Kazusaka H, Matsui M, Saitou M, et al.
Surg Case Rep
. 2024 Aug;
10(1):190.
PMID: 39158760
Background: Papillary thyroid carcinoma rarely undergoes anaplastic transformation. Some risk factors for anaplastic transformation of thyroid cancer are known, but such transformation is difficult to predict in practice. We report...
5.
Kazusaka H, Sugitani I, Toda K, Sen M, Saito M, Nagaoka R, et al.
World J Surg
. 2022 Oct;
47(5):1190-1198.
PMID: 36282283
Background: This cross-sectional study compared patient-reported outcomes of low-risk papillary thyroid carcinoma (PTC, T1N0M0) between patients who underwent active surveillance (AS) and those who received immediate surgery, METHODS: Using the...
6.
Sugitani I, Kazusaka H, Ebina A, Shimbashi W, Toda K, Takeuchi K
World J Surg
. 2022 Aug;
47(2):382-391.
PMID: 35972533
Background: Guidelines universally recommend total thyroidectomy for high-risk papillary thyroid carcinoma (PTC). However, in Japan, thyroid-conserving surgery had been widely applied for such patients until recently. We investigated long-term outcomes...
7.
Nagaoka R, Sugitani I, Kazusaka H, Matsui M, Sen M, Saitou M, et al.
J Nippon Med Sch
. 2021 Sep;
89(3):277-286.
PMID: 34526468
Background: Endoscopic thyroidectomy offers excellent cosmetic outcomes but requires some time for surgeons to become proficient. We examined the learning curve for the first 100 patients treated by a single...
8.
Saitou M, Okamoto M, Nagaoka R, Jikuzono T, Sen M, Kazusaka H, et al.
Surg Case Rep
. 2021 Aug;
7(1):189.
PMID: 34417909
Background: Postoperative bleeding in thyroid surgery is a serious complication with fatal outcomes. Risk factors for postoperative hemorrhage have been reported as old age, male sex, Graves' disease, use of...
9.
Nagaoka R, Ebina A, Toda K, Jikuzono T, Saitou M, Sen M, et al.
World J Surg
. 2021 Jun;
45(9):2769-2776.
PMID: 34100116
Background: Prospective trials of active surveillance (AS) have shown low rates of progression in low-risk papillary thyroid microcarcinoma (PTMC; T1aN0M0). However, the significance of multifocality as a prognostic factor remains...
10.
Sen M, Nagaoka R, Kazusaka H, Matsui M, Saitou M, Sugitani I, et al.
Surg Case Rep
. 2021 May;
7(1):119.
PMID: 33978837
Background: Non-functioning parathyroid carcinoma is an extremely rare malignancy among endocrine tumors. We report a case in which non-functional oxyphilic parathyroid carcinoma was diagnosed from clinical symptoms and pathological diagnosis....